🔎 Trials Near Me

Home › HIV › District of Columbia

Pag-aaral pangklinika para sa HIV sa District of Columbia

9 pag-aaral para sa HIV ang naghahanap ng mga kalahok sa mga site sa District of Columbia.

Mga Lungsod sa District of Columbia

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  • GSK Investigational Site, Washington D.C.
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07650916

El Camino HIV Prevention and Care Study

  • La Clínica del Pueblo, Washington D.C.
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Set 22, 2026 · NCT07834853

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

  • Whitman-Walker Institute ( Site 1538), Washington D.C.
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07266831

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

  • George Washington University, Washington D.C.
Nagre-recruit
Edad 45 hanggang 80 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04949464

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • George Washington University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT05663502

The DC Cohort Longitudinal HIV Status Neutral Study

  • Kaiser Permanente Mid-Atlantic States, Washington D.C.
  • Unity Health Care, Washington D.C.
  • Georgetown University, Washington D.C.
  • at 11 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT01206920

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

  • HIPS (Harm reduction drop-in center), Washington D.C.
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 88 · Lahat ng kasarian · Na-update Okt 31, 2025 · NCT06501781

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

  • GSK Investigational Site, Washington D.C.
Nagre-recruitPhase 1/2
Edad 6 hanggang 12 · Lahat ng kasarian · Na-update Set 19, 2024 · NCT05674656

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

  • Whitman-Walker Health, Washington D.C.
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 15 pataas · Lahat ng kasarian · Na-update Set 28, 2022 · NCT04855773

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.